BioProcess International 2024
September 23 - 26, 2024
Boston, Massachusetts
United States
Share this event
About the Event
At BioProcess International (BPI) 2024, you'll have the opportunity to explore the latest advancements in bioprocessing for biologics and cell & gene therapies. With nine conference tracks to choose from, you’ll have access to novel insights across the entire bioprocessing spectrum and can tailor your experience to the research areas that matter most to you.
We’ll be Unveiling a New Automated Clone Screening System
We’ll be in booth 507 and look forward to introducing you to instruments that can help you accelerate answers and streamline cell line development workflows.
Among the instruments on display will be the Vi-CELL BLU cell viability analyzer, CytoFLEX S flow cytometer, Biomek i5 automated workstation, Optima analytical ultracentrifuge (AUC) and Avanti JXN-26 high-speed centrifuge.
This system enables you to screen clones faster under conditions close to production, all while collecting vital data on cell growth and productivity along the way.
Details About Our Talk
Monoclonal antibody therapies have revolutionized treatment options, especially for cancer and autoimmune disease patients. Rapid development of new antibodies requires an efficient cell line development process to reduce time to market.
In this talk, Anna Kress will discuss the importance of high-throughput screening under near-production conditions and the challenges of limited lab automation. You’ll hear how an automated workflow for CHO clone cultivation and analysis can streamline development, minimize errors and identify promising candidates.
Join us on Wednesday, September 25, from 12:30–1:00 p.m. to discover how data-driven decisions can transform antibody therapies.
